Host defense strategies encompass resistance to reduce pathogen burden, and disease tolerance to preserve host fitness.
1 Immunedriven resistance mechanisms have inevitably a negative impact on host fitness and can lead to immunopathology. Disease tolerance limit immunopathology and therefore disease severity by preventing tissue damage or ameliorating tissue function without interfering with pathogen load. Several pathways cooperate to protect the host. These pathways include metabolic and oxidative stress responses, 2 and the interaction between neuroendocrine system and the immune system 3 to favor resolution of inflammation and to prevent tissue damage.
It has long been recognized a complex functional linkage between the immune and the nervous systems. In infectious insults, proinflammatory cytokines activate the hypothalamic-pituitary-adrenal (HPA) axis resulting in the release of adrenal glucocorticoids (GC). 4 GC exert their actions through their cytoplasmic receptors which translocate to the nucleus and act as a ligand-dependent transcription factor that modulates the expression of glucocorticoid-responsive genes or modifies the activity of other transcription factors such as nuclear factor-κB and activator protein-1. GC affect multiple cell targets and possess numerous immunomodulatory functions: in inflammatory conditions, they suppress the expression of cytokines, chemokines, and adhesion molecules, but they can also have proinflammatory effects such as enhancement of Th2 cytokine production. 5 Murine cytomegalovirus (MCMV) infection has been used extensively as a model to study the immune response to the herpes virus CMV, and more particularly the implication of natural killer (NK) cells. It has long been shown that endogenous GC response is protective against cytokine-induced pathology in MCMV infection, but the mechanisms involved are unclear. 6 In a recent work, Quatrini et al. 7 investigated the role of GC receptors in innate lymphoid cell (ILC) subsets producing IFN-γ (i.e., NK cells and ILC1), during MCMV infection. They used a conditional knockout mouse model in which the gene encoding the GC receptor (GR; encoded by the nuclear receptor subfamily 3 group C member 1 gene Nr3c1) is selectively deleted in ILC expressing NCR1. Ncr1 and WT Ncr1-iCre NK cells, suggesting that the inhibition of IFN-γ expression by GC is tissue specific. Histological analysis of the spleen indicated that GR Ncr1-iCre mice had more substantial lesions. In contrast, no significant difference between GR Ncr1-iCre and WT Ncr1-iCre mice was observed in the nature or extent of the liver lesions. The viral load in the spleen and liver of GR Ncr1-iCre was similar to that in WT Ncr1-iCre mice, indicating that the inflammationinduced tissue damage was not due to an impairment of viral clearance. All these observations showed that endogenous GC produced during MCMV infection downregulated IFN-γ expression by spleen NK cells without any change in NK cell cytotoxic functions, and most importantly, that the control of viral infection was maintained.
In order to better understand the mechanisms involved in the regulation of NK cell functions by endogenous GC, Quatrini et al. sorted spleen and liver NK cells, as well as liver ILC1s from GR Ncr1-iCre and WT Ncr1-iCre MCMV-infected mice and performed RNAbased next-generation sequencing. The analysis suggested that the regulation of gene expression by GC was specific to both organ and cell lineage. They focused on the expression of genes that were differentially expressed in GR Ncr1-iCre and WT Ncr1-iCre spleen NK cells. Pdcd1 which encodes programmed death receptor (PD)-1 was found to be significantly downregulated in spleen NK cells from GR Ncr1-iCre mice after infection. PD-1 is an inhibitory cell-surface receptor that downregulates cytolysis and cytokine production, including IFN-γ in T lymphocytes. In the article by Quatrini et al., PD-1 was found to be expressed exclusively on the surface of spleen NK cells from MCMV-infected WT Ncr1-iCre mice, suggesting that PD-1 expression was dependent on the GC-GR pathway. PD-1 expression was not observed on spleen NK cells from uninfected mice, or on liver NK cells from infected mice. Modification of PD-1 expression was specific to NK cells as PD-1 expression was unchanged on T cells after MCMV infection, and was not found on liver ILC1. As NK cells from both spleen and liver expressed GR, the authors assumed that the tissue-specific effect of GC may be dependent on the presence of tissue-specific inflammatory cytokines. Only IL-15 mRNA expression was higher in the spleen but not in the liver of MCMVinfected mice of both genotype. In vitro, treatment with corticosterone in combination with IL-15 and IL-18 induced PD-1 expression only on NK cells from WT Ncr1-iCre mice. These results emphasize that tissue-specific cytokine environment in conjunction with GC may increase PD-1 expression on NK cells, although neither the cell origin of these cytokines, nor their receptor expression were elucidated. They also underscore that several requirements are necessary to finely control NK cells. In order to evaluate if PD-1 regulation is involved in the downregulation of IFN-γ production, PD-1-blocking antibody was administered before activation of the HPA axis and thus before the peak of blood corticosterone. Neutralization of PD-1 increased the frequency of IFN-γ-expressing spleen NK cells in WT Ncr1-iCre mice similarly to that in GR Ncr1-iCre mice treated with control antibody, revealing that during MCMV infection, PD-1 signaling in spleen NK cells limited their production of IFN-γ. In another recent paper, a fully mature NK cell subset was found to highly express PD-1 in the peripheral blood of healthy donors serologically positive for CMV. These PD-1 + NK cells exhibited a reduced proliferative capability in response to cytokines, low degranulation, and impaired cytokine production on interaction with tumor targets. 8 Therefore, although the article by Quatrini et al. evidences a mechanism by which PD-1 is increased after CMV infection, the dissociation between the two main NK cell functions is puzzling. Interestingly, in a setting of active CMV infection in children undergoing hematopoietic stem cell transplantation for hematological malignancies, mature NK cells were poor IFN-γ producers in response to IL-12 and IL-18, although they responded efficiently to target cells. 9 While PD-1 was not measured in this study, its expression is usually found on a subset of mature NK cells, questioning its implication in this study. A better understanding of PD-1 regulation might open new perspectives for therapeutic intervention on NK cell in different diseases. Nevertheless, caution must be undertaken as PD-1/PD-L1 pathway has detrimental effect on host fitness, for example by blocking immune response against tumor cells.
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Altogether, the article by Quatrini et al. emphasizes a neuroendocrine control of IFN-γ production by NK cells through PD-1 molecule, involving GC and dampening spleen damages without affecting viral clearance (Fig. 1) . HPA axis is one of the arm of the stress response; the other one being the sympathetic nervous system. Stress is an essential response to restore homeostasis, but chronic stress is deleterious to immune function. Therefore, it might be of interest to evaluate the GC-induced regulation of PD-1 expression by NK cells in different stressful conditions. Moreover, GC frequently act in concert with other stress hormones such as catecholamines (norepinephrine and epinephrine) produced by the sympathetic nervous system. For example, both corticosterone and catecholamines were shown to be necessary in the stress-induced suppression of herpes simplex virus-1-specific cytotoxic T lymphocytes. 11 Strikingly, NK cells express β2-adrenergic receptors (one of the catecholamine receptor), which control circulation and adhesion of NK cells. 12 Therefore, evaluating the role of catecholamines in the regulation of NK cell functions during MCMV infection in normal or stressful conditions would also be noteworthy. IL-18 was found to be necessary for the increased expression of PD-1 on spleen NK cells. 7 Thrillingly, IL-18 is produced in endocrine tissues, including the adrenal and the pituitary glands. Its production is increased during stress by activation of the HPA axis and some studies have suggested that IL-18 may even participate in the regulation of the HPA axis, 13 questioning the role of IL-18 in this setting. Moreover, one might consider that GC biosynthesis and secretion is under circadian regulation, 14 which may affect the regulation of NK cell functions. Quatrini et al. mentioned that mice were infected at 2 p. m., 7 but we do not know if the PD-1 expression of NK cells is following a circadian rhythm or is affected by the rhythmicity of GC expression. Finally, the consequences of exogenous versus endogenous corticosteroid impregnation on the PD-1/PD-L1 pathway of NK cells should be explored. Therefore, the study by Quatrini et al. lifts a corner of the veil, but there are still many mechanisms to unravel to safely use new therapeutics targeting GC-PD-1 axis. Fig. 1 Regulation of spleen immunopathology by NK cells during MCMV infection involves HPA-GC-PD-1 axis. HPA axis is activated during MCMV infection and increases GC production. In conjunction with cytokine microenvironment of the spleen, GC upregulates PD-1 expression on NK cells, responsible for decreased expression of IFN-γ leading to decreased immunopathology. The place of SNS and other stress hormones capable of regulating NK cells has yet to be studied. Severe and chronic stress is associated with hypertrophy of adrenal cortex and reduced sensitivity of HPA axis to negative feedback. Hence chronic stressors can affect susceptibility to infection through GC mediated suppression of immune responses. Therefore, chronic stress, but also clock control of GC secretion, and bacterial secondary infection may complicate the picture. CRH corticotropin-releasing hormone, ACTH adrenocorticotropic hormone, GC glucocorticoid (cortisol in human, corticosterone in rodent), SNS sympathetic nervous system, NE norepinephrine, E epinephrine, PNMT phenylethanolamine-N-methyltransferase, NK natural killer
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